EXOME SEQUENCING IN BIPOLAR DISORDER REVEALS SHARED RISK GENE AKAP11 WITH SCHIZOPHRENIA

Here we report results from the Bipolar Exome (BipEx) collaboration analysis of whole exome sequencing of 13,933 individuals diagnosed with bipolar disorder (BD), matched with 14,422 controls. We find an excess of ultra-rare protein-truncating variants (PTVs) in BD patients among genes under strong evolutionary constraint, a signal evident in both major BD subtypes, bipolar 1 disorder (BD1) and bipolar 2 disorder (BD2). We also find an excess of ultra-rare PTVs within genes implicated from a recent schizophrenia exome meta-analysis (SCHEMA; 24,248 SCZ cases and 97,322 controls) and among binding targets of CHD8. Genes implicated from GWAS of BD, however, are not significantly enriched for ultra-rare PTVs. Combining BD gene-level results with SCHEMA, AKAP11 emerges as a definitive risk gene (ultra-rare PTVs seen in 33 cases and 13 controls, OR = 7.06, P = 2.83 x 10-9). At the protein level, AKAP-11 is known to interact with GSK3B, the hypothesized mechanism of action for lithium, one of the few treatments for BD. Overall, our results lend further support to the polygenic basis of BD and demonstrate a role for rare coding variation as a significant risk factor in BD onset.

[1]  Hoang T. Nguyen,et al.  Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder , 2021, Molecular Psychiatry.

[2]  S. Gabriel,et al.  Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia , 2020, medRxiv.

[3]  M. Daly,et al.  Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations , 2019, Nature Neuroscience.

[4]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[5]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[6]  Jakob Grove,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[7]  Michael R. Johnson,et al.  Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals , 2019, bioRxiv.

[8]  N. Craddock,et al.  Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases , 2018, Biological Psychiatry.

[9]  E. Génin,et al.  Identification of potential genetic risk factors for bipolar disorder by whole-exome sequencing , 2018, Translational Psychiatry.

[10]  C. Sabatti,et al.  Contribution of common and rare variants to bipolar disorder susceptibility in extended pedigrees from population isolates , 2018, bioRxiv.

[11]  Alicia R. Martin,et al.  Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. , 2018, American journal of human genetics.

[12]  John P. Rice,et al.  Genomic dissection of bipolar disorder and schizophrenia including 28 subphenotypes 1 2 Primary , 2018 .

[13]  C. Greenwood,et al.  Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors , 2018, Molecular Psychiatry.

[14]  Elvira Bramon,et al.  The contribution of rare variants to risk of 1 schizophrenia in individuals with and without 2 intellectual disability , 2017 .

[15]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[16]  S. Abera,et al.  Trends, causes, and risk factors of mortality among children under 5 in Ethiopia, 1990–2013: findings from the Global Burden of Disease Study 2013 , 2016, Population health metrics.

[17]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[18]  T. Vos,et al.  The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013 , 2016, Bipolar disorders.

[19]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[20]  Patrick F. Sullivan,et al.  Ultra-rare disruptive and damaging mutations influence educational attainment in the general population , 2016, Nature Neuroscience.

[21]  O. Andreassen,et al.  Subcortical volumetric abnormalities in bipolar disorder , 2016, Molecular Psychiatry.

[22]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[23]  P. Visscher,et al.  Nature Genetics Advance Online Publication , 2022 .

[24]  R. Jope,et al.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. , 2015, Pharmacology & therapeutics.

[25]  Stephan J Sanders,et al.  The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment , 2015, Nature Communications.

[26]  Michael Q. Zhang,et al.  HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. , 2014, Cell reports.

[27]  B. Kishore,et al.  Lithium: a versatile tool for understanding renal physiology. , 2013, American journal of physiology. Renal physiology.

[28]  P. McGuffin,et al.  Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. , 2013, JAMA psychiatry.

[29]  J. Beaulieu,et al.  Inhibition of GSK3 by lithium, from single molecules to signaling networks , 2012, Front. Mol. Neurosci..

[30]  J. Weeks.  An introduction to population , 2012 .

[31]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[32]  Shamil R Sunyaev,et al.  Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.

[33]  N. Sartorius,et al.  The ICD-10 Symptom Checklist: a companion to the ICD-10 Classification of Mental and Behavioural Disorders , 1993, Social Psychiatry and Psychiatric Epidemiology.

[34]  R. Jope.  Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. , 2003, Trends in pharmacological sciences.

[35]  N. Yorioka,et al.  A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta. , 2002, The Journal of biological chemistry.

[36]  M. Kimura,et al.  An introduction to population genetics theory , 1971 .